Fortrea Holdings (FRA:K67) Preferred Dividends : €0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Fortrea Holdings Preferred Dividends?

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Fortrea Holdings's preferred dividends for the three months ended in Mar. 2024 was €0 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Mar. 2024 was €0 Mil.

Fortrea Holdings Preferred Dividends Historical Data

The historical data trend for Fortrea Holdings's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fortrea Holdings Preferred Dividends Chart

Fortrea Holdings Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Preferred Dividends

Fortrea Holdings Quarterly Data
	Dec20	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Preferred Dividends	Get a 7-Day Free Trial						-	-	-	-	-

Fortrea Holdings Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.

Fortrea Holdings (FRA:K67) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

Fortrea Holdings (FRA:K67) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fortrea Holdings Inc (FRA:K67) » Definitions » Preferred Dividends

Comparable Companies

Traded in Other Exchanges

FTRE:USA FTRE1:Mexico

Address

8 Moore Drive, Durham, NC, USA, 27709

Website

https://www.fortrea.com

Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after LabCorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Fortrea Holdings (FRA:K67) Headlines

No Headlines